Importantly, our further assays demonstrated that the HIF-1 signaling pathway underwent significant oxidation changes in pancreatic cancer cells, and the altered oxidation in PHD2 proteins was closely correlated with survival time in PDAC patients. This evidence concerns the gene EGLN1 and pancreatic neoplasm.